Sigma Planning Corp Chembio Diagnostics, Inc. Transaction History

Sigma Planning Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$1.09 - $2.55 $21,037 - $49,215	-19,300 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$2.06 - $5.34 $3,090 - $8,010	1,500 Added 8.43%	19,300 $48,000
Q2 2021 Aug 13, 2021	SELL	$2.88 - $5.64 $11,520 - $22,560	-4,000 Reduced 18.35%	17,800 $53,000
Q1 2021 May 06, 2021	BUY	$3.4 - $7.97 $1,360 - $3,188	400 Added 1.87%	21,800 $77,000
Q4 2020 Feb 09, 2021	BUY	$4.11 - $7.51 $87,954 - $160,714	21,400 New	21,400 $102,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.